Home > Press > Interim Management Statement January 2008
Abstract:
Oxford Instruments plc, the high technology tools and systems company, issues today an Interim Management Statement which covers the period from 1 October 2007 to 14 January 2008, as required by the UK Listing Authority's Disclosure and Transparency Rules.
Interim Management Statement January 2008
UK | Posted on January 14th, 2008
Our core environmental and nanotechnology markets remain robust despite market concerns over global economic conditions. Our Research and Development programme continues to convert our technological capabilities into innovative new products, meeting the needs of our customers. This combination of robust markets and commercially orientated innovation has helped to ensure that our organic growth plans remain on track. Furthermore, the integration of our two recent acquisitions, Vericold and WAS, is proceeding to plan with strong trading results to date from both companies.
Save as described in this statement, there has been no significant change in the financial position of the Group in the period. The Board continues to be confident that the Group's full year performance will meet expectations.
####
About Oxford Instruments plc
Oxford Instruments specialises in the design, manufacture and support of high-technology tools and systems for industry, research, education, space, energy, defence and healthcare.
We combine core technologies in areas such as low temperature and high magnetic field environments; X-ray, electron and optical based metrology; nuclear magnetic resonance, advanced growth, deposition and etching.
Our aim is to be the leading provider of tools and systems for the emerging nanotechnology and bioscience markets.
For more information, please click here
Contacts:
Jonathan Flint
Chief Executive
Enquiries:
Oxford Instruments plc Tel: 01865 393200
Jonathan Flint, Chief Executive
Kevin Boyd, Group Finance Director
Hogarth Partnership Limited Tel: 020 7357 9477
Rachel Hirst / Andrew Jaques / Ian Payne
Copyright © Business Wire 2008
If you have a comment, please
Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Bookmark:
News and information
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Announcements
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Study Shows How the Nanog Protein Promotes Growth of Head and Neck Cancer June 18th, 2013
New Method to Synthesize Zinc Oxide Nanoparticles with High Catalytic Activity June 18th, 2013
Production of Polyaniline Biosensors Modified with Conductive Polymer Composites June 18th, 2013
Tools
Beneq’s comprehensive industrial Thin Film Coating Services shorten time to market June 18th, 2013
Which qubit my dear? New method to distinguish between neighbouring quantum bits June 18th, 2013
Pioneering breakthrough of chemical nanoengineering to design drugs controlled by light June 18th, 2013
Hitachi announces the SU8200 – a new type of cold field emitter SEM June 17th, 2013
Financial Reports
Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013
Harris & Harris Group Reports Financial Statements as of March 31, 2013 May 10th, 2013
Arrowhead Reports Fiscal 2013 Second Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time May 9th, 2013
Arrowhead to Report Fiscal 2013 Second Quarter Financial Results - Conference Call Scheduled for Thursday, May 9, 2013 May 2nd, 2013